Work

Discovery of Small Molecule Inhibitors of PCSK9 Using Virtual Screening as Potential Therapeutics for Atherosclerosis

Year: 2026

Type: article

Abstract: High LDL cholesterol can cause heart disease. Current treatments like statins are not always effective, so new therapies are needed. PCSK9 is a protein that reduces the number of LDL receptors in the liver, which keeps cholesterol in the blood, making it a strong target for

Source: European Journal of Biomedical and Life Sciences

DOI: 10.29013/ejbls-26-1-15-32

Author: Matthew N. Siciliano

Language: English

Topic: Computational Drug Discovery Methods

Subfield: Computational Theory and Mathematics

Field: Computer Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W7155686591

FWCI:

Cites:

Cited by:

Related to: